Role of Endogenous Bradykinin in Human Coronary Vasomotor Control
- 15 December 1995
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 92 (12) , 3424-3430
- https://doi.org/10.1161/01.cir.92.12.3424
Abstract
Background Bradykinin is a potent vasodilator that acts through B2 kinin receptors to stimulate the release of endothelium-derived nitric oxide, prostacyclin, and hyperpolarizing factor. In this study, we investigated the contribution of endogenous bradykinin to vasomotor control in the human coronary circulation. Methods and Results The selective bradykinin B2 receptor antagonist HOE 140 was infused into the left main coronary artery (200 μg/min for 15 minutes) in 15 patients without significant coronary stenoses. Epicardial responses were evaluated by quantitative coronary blood flow with a Doppler flow-velocity wire. Flow-dependent dilation (n=10; intracoronary papaverine) and acetylcholine responses (n=5) were assessed before and after HOE 140. After HOE 140, there was a reduction in luminal area in the proximal (P<.001), mid (P<.001), and distal (P<.05) coronary arteries. HOE 140 led to an increase in coronary vascular resistance (P<.001) and a decrease in coronary blood flow (P<.001). After bradykinin B2 receptor blockade, there was a reduction in flow-dependent dilation (23.4±6.9% to 3.9±6.0%, P<.001), the extent of which correlated with the degree of basal vasoconstriction after HOE 140 in the same vessel segment (P<.05). Acetylcholine responses were unchanged after HOE 140. Conclusions The results of this study demonstrate for the first time a role for endogenous bradykinin in mediating normal vasomotor responses in resistance and epicardial coronary vessels under basal and flow-stimulated conditions in the human coronary circulation.Keywords
This publication has 24 references indexed in Scilit:
- Endothelium-dependent hyperpolarization caused by bradykinin in human coronary arteries.Journal of Clinical Investigation, 1993
- Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginineThe Lancet, 1991
- Kinins and Endothelium-Dependent Relaxations to Converting Enzyme Inhibitors in Perfused Canine ArteriesJournal of Cardiovascular Pharmacology, 1991
- Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin.Hypertension, 1991
- Effects of bradykinin and prostaglandin inhibition on systemic and regional hemodynamics in conscious normotensive ratsJournal Of Hypertension, 1991
- Effects of inhibition of nitric oxide formation on basal vasomotion and endothelium-dependent responses of the coronary arteries in awake dogs.Journal of Clinical Investigation, 1991
- Rat aortic smooth muscle cells in culture express kallikrein, kininogen, and bradykininase activity.Journal of Clinical Investigation, 1990
- EFFECTS OF ENDOTHELIUM-DERIVED NITRIC OXIDE ON PERIPHERAL ARTERIOLAR TONE IN MANThe Lancet, 1989
- EDRF coordinates the behaviour of vascular resistance vesselsNature, 1987
- Flow-Dependent, Endothelium-Mediated Dilation of Epicardial Coronary Arteries in Conscious DogsJournal of Cardiovascular Pharmacology, 1984